Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5A2R

A New Crystal Structure of the Drosophila melanogaster Angiotensin Converting Enzyme Homologue AnCE.

Summary for 5A2R
Entry DOI10.2210/pdb5a2r/pdb
DescriptorANGIOTENSIN-CONVERTING ENZYME, D-MALATE, ZINC ION, ... (6 entities in total)
Functional Keywordshydrolase, angiotensin converting enzyme, drosophila melanogaster, drosophila proteins, animals, peptidyl- dipeptidase a, molecular structure
Biological sourceDROSOPHILA MELANOGASTER (FRUIT FLY)
Total number of polymer chains1
Total formula weight69932.66
Authors
Harrison, C.,Acharya, K.R. (deposition date: 2015-05-22, release date: 2015-08-26, Last modification date: 2024-11-13)
Primary citationHarrison, C.,Acharya, K.R.
A New High-Resolution Crystal Structure of the Drosophila Melanogaster Angiotensin Converting Enzyme Homologue, Ance.
FEBS Open Bio, 5:661-, 2015
Cited by
PubMed Abstract: Angiotensin converting enzyme (ACE) is a zinc-dependent dipeptidyl carboxypeptidase with an essential role in blood pressure homeostasis in mammals. ACE has long been targeted in the treatment of hypertension through ACE inhibitors, however current inhibitors are known to cause severe side effects. Therefore, there is a requirement for a new generation of ACE inhibitors and structural information will be invaluable in their development. ACE is a challenging enzyme to work with due to its extensive glycosylation. As such, the Drosophila melanogaster ACE homologue, AnCE, which shares ∼60% sequence similarity with human ACE, can be used as a model for studying inhibitor binding. The presence of ligands originating from the crystallisation condition at the AnCE active site has proved an obstacle to studying the binding of new inhibitor precursors. Here we present the crystal structure of AnCE (in a new crystal form) at 1.85 Å resolution, using crystals grown under different conditions. This new structure may be more suitable for studying the binding of new compounds, with the potential of developing a new generation of improved ACE inhibitors.
PubMed: 26380810
DOI: 10.1016/J.FOB.2015.08.004
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.85 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon